Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Development Platform at the 40th Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics (MDx) company, today, unveiled its blueprint for the future during a...

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,Seegene Mdx ,Jong Yoon Chun ,Prnewswire Seegene Inc ,Seegene Inc ,Pharmaceuticals ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,New Products Amp Services ,